Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
4355 | 1724 | 45.0 | 94% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | P73 | Author keyword | 393 | 64% | 23% | 389 |
2 | P63 | Author keyword | 219 | 43% | 22% | 387 |
3 | DELTA NP73 | Author keyword | 41 | 87% | 1% | 20 |
4 | P53 FAMILY | Author keyword | 38 | 59% | 2% | 43 |
5 | TP63 | Author keyword | 36 | 70% | 2% | 30 |
6 | TAP73 | Author keyword | 33 | 83% | 1% | 19 |
7 | DELTA NP63 | Author keyword | 20 | 56% | 1% | 24 |
8 | TAP63 | Author keyword | 17 | 70% | 1% | 14 |
9 | DNP73 | Author keyword | 17 | 100% | 0% | 8 |
10 | P73 GENE | Author keyword | 15 | 77% | 1% | 10 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | P73 | 393 | 64% | 23% | 389 | Search P73 | Search P73 |
2 | P63 | 219 | 43% | 22% | 387 | Search P63 | Search P63 |
3 | DELTA NP73 | 41 | 87% | 1% | 20 | Search DELTA+NP73 | Search DELTA+NP73 |
4 | P53 FAMILY | 38 | 59% | 2% | 43 | Search P53+FAMILY | Search P53+FAMILY |
5 | TP63 | 36 | 70% | 2% | 30 | Search TP63 | Search TP63 |
6 | TAP73 | 33 | 83% | 1% | 19 | Search TAP73 | Search TAP73 |
7 | DELTA NP63 | 20 | 56% | 1% | 24 | Search DELTA+NP63 | Search DELTA+NP63 |
8 | TAP63 | 17 | 70% | 1% | 14 | Search TAP63 | Search TAP63 |
9 | DNP73 | 17 | 100% | 0% | 8 | Search DNP73 | Search DNP73 |
10 | P73 GENE | 15 | 77% | 1% | 10 | Search P73+GENE | Search P73+GENE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | P53 HOMOLOG | 374 | 68% | 19% | 332 |
2 | P73 | 205 | 50% | 17% | 300 |
3 | P53 RELATED PROTEIN | 171 | 81% | 6% | 104 |
4 | DELTA NP73 | 158 | 89% | 4% | 72 |
5 | KINASE C ABL | 135 | 65% | 7% | 129 |
6 | DELTA NP63 ALPHA | 122 | 81% | 4% | 73 |
7 | P63 | 118 | 31% | 19% | 320 |
8 | HAY WELLS SYNDROME | 99 | 88% | 3% | 46 |
9 | P53 FAMILY | 94 | 62% | 6% | 96 |
10 | WILD TYPE P73 | 75 | 91% | 2% | 31 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53 | 2011 | 80 | 115 | 77% |
p63 and p73: Roles in development and tumor formation | 2004 | 287 | 165 | 81% |
How the TP53 Family Proteins TP63 and TP73 Contribute to Tumorigenesis: Regulators and Effectors | 2014 | 11 | 151 | 70% |
p63 steps into the limelight: crucial roles in the suppression of tumorigenesis and metastasis | 2013 | 23 | 91 | 81% |
p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress | 2006 | 246 | 67 | 63% |
A balancing act: orchestrating amino-truncated and full-length p73 variants as decisive factors in cancer progression | 2015 | 2 | 193 | 62% |
p63 and p73 in human cancer: defining the network | 2007 | 130 | 153 | 85% |
MicroRNAs and p63 in epithelial stemness | 2015 | 3 | 68 | 41% |
p63/p73 in the control of cell cycle and cell death | 2012 | 25 | 58 | 88% |
TP63 and TP73 in cancer, an unresolved "family" puzzle of complexity, redundancy and hierarchy | 2014 | 7 | 170 | 73% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | IDI IRCCS | 12 | 37% | 1.5% | 26 |
2 | BIOCHEM IDI IRCCS | 10 | 47% | 0.9% | 16 |
3 | INSERM EUROPEAN ASSOCIATED | 6 | 80% | 0.2% | 4 |
4 | INTERNAL MED HEPATOL GASTROENTEROL 4 | 5 | 60% | 0.3% | 6 |
5 | INSERTECH | 5 | 47% | 0.5% | 8 |
6 | IKAWA | 5 | 63% | 0.3% | 5 |
7 | IDI IRCCS BIOCHEM | 5 | 41% | 0.5% | 9 |
8 | CLIN SCI ENT | 4 | 67% | 0.2% | 4 |
9 | DESARROLLO GANADERO | 4 | 67% | 0.2% | 4 |
10 | BIOCHEM IDI IRCC | 4 | 75% | 0.2% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000225745 | MUTANT P53//GAIN OF FUNCTION//CANC THER EUT S |
2 | 0.0000116800 | IASPP//ASPP2//53BP2 |
3 | 0.0000104377 | MDM2//MDMX//NUTLIN 3 |
4 | 0.0000088011 | EDAR//HYPOHIDROTIC ECTODERMAL DYSPLASIA//ECTODERMAL DYSPLASIA |
5 | 0.0000071560 | WWP1//SMURF1//CKIP 1 |
6 | 0.0000062034 | P53 CODON 72//P53 POLYMORPHISM//CODON 72 POLYMORPHISM |
7 | 0.0000058346 | P53 GENE//P53 MUTANTS//MUTANT P53 |
8 | 0.0000053265 | DISSEMINATED NEOPLASIA//HAEMIC NEOPLASIA//MYA ARENARIA |
9 | 0.0000053208 | FIBULAR HEMIMELIA//TIBIAL HEMIMELIA//ECTRODACTYLY |
10 | 0.0000045544 | SESTRIN 2//TP53INP1//SESTRIN |